Getting serious about climate change Good, Bad: Medical device bill passes Wanted: New home for money Tricked by your health insurance? |
Tag Archives: United States Congress
Export – Import Bank Reauthorization … signed

What does $700 million get you?

What are pharmaceutical, biotech, and medical device companies trying to buy with $700,000,000? Massive influence with our government.
| Don’t allow science to take a back seat to the financial interests of corporations! Urge the FDA to protect the American people from unsafe food, drugs, and medical devices by protecting science from corporate interference. |
That’s the amount of money these companies spent over the last three years lobbying Congress and the Executive Branch, which includes the Food and Drug Administration (FDA). And now, with negotiations underway on legislation that will govern how the FDA approves and monitors prescription drugs and medical products, it’s clear that all that money has bought the industry a lot of influence with our legislators.
We can’t allow science to take a back seat to the financial interests of corporations—especially when our lives are on the line.
We have seen many concerted efforts from industry lobbyists to roll back key safeguards at the FDA that protect science from corporate interference. The FDA’s foremost priority is to protect the American people from unsafe food, drugs, and medical devices. That requires the agency use the best available science when determining whether products are safe or not.
It’s time we remind the FDA to put safety first.
Take Action Today!
Sincerely,
Michael Halpern Program Manager UCS Scientific Integrity Program
P.S. Don’t Forget: Give to the Union of Concerned Scientists today and your gift will go twice as far—helping to challenge attacks on science and stand up to corporate-sponsored misinformation.
President Obama Speaks …

click on link below for video
Congresssional Budget Office
Economic Effects of Reducing the Fiscal Restraint That Is Scheduled to Occur in 2013
Policymakers are facing difficult trade-offs in formulating the nation’s fiscal policies. On the one hand, if the fiscal policies currently in place are continued in coming years, the revenues collected by the federal government will fall far short of federal spending, putting the budget on an unsustainable path. On the other hand, immediate spending cuts or tax increases would represent an added drag on the weak economic expansion.
CBO Analyzes Effects of Fiscal Restraint Scheduled Under Current Law
Policymakers face difficult trade-offs in deciding how quickly to implement policies to reduce budget deficits. On the one hand, cutting spending or increasing taxes slowly would lead to a greater accumulation of government debt; on the other hand, immediate spending cuts or tax increases would represent an added drag on the weak economic expansion.
CBO Estimate of the Statutory Pay-As-You-Go Effects for Senate Amendment 2122 in the Nature of a Substitute to S. 3187, the Food and Drug Administration Safety and Innovation Act




You must be logged in to post a comment.